Imami N - Search Results

1

Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection.

Morlese JF, Orkin CM, Abbas R, Burton C, Qazi NA, Nelson MR, Imami N, Gazzard BG. Morlese JF, et al. Among authors: imami n. AIDS. 2003 Jun 13;17(9):1411-3. doi: 10.1097/00002030-200306130-00025. AIDS. 2003. PMID: 12799572 No abstract available.

2

Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.

Powles T, Imami N, Nelson M, Gazzard BG, Bower M. Powles T, et al. Among authors: imami n. AIDS. 2002 Mar 8;16(4):531-6. doi: 10.1097/00002030-200203080-00003. AIDS. 2002. PMID: 11872995

3

Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy.

Sullivan AK, Hardy GA, Nelson MR, Gotch F, Gazzard BG, Imami N. Sullivan AK, et al. Among authors: imami n. AIDS. 2003 Mar 7;17(4):628-9. doi: 10.1097/00002030-200303070-00020. AIDS. 2003. PMID: 12598786

4

Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses.

Hardy GA, Imami N, Sullivan AK, Nelson MR, Gazzard B, Gotch FM. Hardy GA, et al. Among authors: imami n. AIDS. 2004 Nov 5;18(16):2199-202. doi: 10.1097/00002030-200411050-00014. AIDS. 2004. PMID: 15577655

5

Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy.

Mela CM, Burton CT, Imami N, Nelson M, Steel A, Gazzard BG, Gotch FM, Goodier MR. Mela CM, et al. Among authors: imami n. AIDS. 2005 Nov 4;19(16):1761-9. doi: 10.1097/01.aids.0000183632.12418.33. AIDS. 2005. PMID: 16227783

6

Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients.

Rosignoli G, Cranage A, Burton C, Nelson M, Steel A, Gazzard B, Gotch F, Imami N. Rosignoli G, et al. Among authors: imami n. AIDS. 2007 Jun 19;21(10):1379-81. doi: 10.1097/QAD.0b013e3281de7296. AIDS. 2007. PMID: 17545722

7

Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection.

Burton CT, Hardy GA, Sullivan AK, Nelson MR, Gazzard B, Gotch FM, Imami N. Burton CT, et al. Among authors: imami n. Clin Exp Immunol. 2002 Nov;130(2):286-92. doi: 10.1046/j.1365-2249.2002.01993.x. Clin Exp Immunol. 2002. PMID: 12390317 Free PMC article. Clinical Trial.

8

Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infection.

Burton CT, Nelson MR, Hay P, Gazzard BG, Gotch FM, Imami N. Burton CT, et al. Among authors: imami n. Clin Exp Immunol. 2005 Nov;142(2):354-61. doi: 10.1111/j.1365-2249.2005.02918.x. Clin Exp Immunol. 2005. PMID: 16232224 Free PMC article.

9

Immune reconstitution in HIV-1-infected patients.

Imami N, Hardy G, Pires A, Burton C, Pido-Lopez J, Mela C, Gotch F. Imami N, et al. Curr Opin Investig Drugs. 2002 Aug;3(8):1138-45. Curr Opin Investig Drugs. 2002. PMID: 12211404 Review.

10

Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune).

Pido-Lopez J, Burton C, Hardy G, Pires A, Sullivan A, Gazzard B, Aspinall R, Gotch F, Imami N. Pido-Lopez J, et al. Among authors: imami n. AIDS Res Hum Retroviruses. 2003 Feb;19(2):103-9. doi: 10.1089/088922203762688603. AIDS Res Hum Retroviruses. 2003. PMID: 12639245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters